This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The General Hospital Corporation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Rafael Pieretti-Vanmarcke: Innovator in Ovarian Cancer Research
Introduction
Rafael Pieretti-Vanmarcke is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of ovarian cancer research through his innovative work. His dedication to advancing medical science is evident in his patented inventions aimed at improving the diagnosis and treatment of ovarian cancer.
Latest Patents
Rafael holds a patent for a groundbreaking invention titled "Collecting ovarian cancer stem cells from ovarian cancer cells." This invention relates to compositions and methods for treating, characterizing, and diagnosing ovarian cancer. The patent outlines methods for treating and preventing ovarian cancer by administering effective amounts of Mullerian Inhibiting substance and agents that inhibit BCRP1. Additionally, it provides methods to identify and enrich populations of ovarian cancer stem cells and somatic ovarian stem cells, including specific markers for these cells.
Career Highlights
Rafael is associated with The General Hospital Corporation, where he continues to contribute to cancer research. His work has the potential to significantly impact the way ovarian cancer is treated and understood. With a focus on innovative solutions, he aims to enhance patient outcomes through his research.
Collaborations
Rafael collaborates with esteemed colleagues such as Paul P. Szotek and Patricia K. Donahoe. Their combined expertise fosters a collaborative environment that drives forward the research and development of new cancer treatments.
Conclusion
Rafael Pieretti-Vanmarcke is a pioneering inventor whose work in ovarian cancer research is making a difference in the medical field. His innovative patent and collaborations highlight his commitment to improving cancer treatment and diagnosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
